Price Target Update on Corning Incorporated (NYSE:GLW)

Corning Incorporated (NYSE:GLW) has been rated by 9 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $23 and the lowest price target forecast is $15. The average forecast of all the analysts is $18.33 and the expected standard deviation is $3.11.

Other Equity analysts have also commented on the company shares. Standpoint Research downgrades its rating on Corning Incorporated (NYSE:GLW). Analysts at the Standpoint Research have a current rating of Hold on the shares. The shares were previously rated Buy. The rating by the firm was issued on June 13, 2016.

Corning Incorporated (NYSE:GLW): stock turned positive on Thursday. Though the stock opened at $20.79, the bulls momentum made the stock top out at $20.9 level for the day. The stock recorded a low of $20.59 and closed the trading day at $20.79, in the green by 1.17%. The total traded volume for the day was 6,270,901. The stock had closed at $20.55 in the previous days trading.

On the companys insider trading activities, The officer (Senior Vice President and CFO), of Corning Inc /Ny, Tripeny R Tony had unloaded 7,500 shares at $21.17 per share in a transaction on June 7, 2016. The total value of transaction was $158,775. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Corning Incorporated (Corning) is engaged in the manufacture of specialty glass and ceramics. The Company creates and makes keystone components that enable systems for consumer electronics, mobile emissions control, optical communications and life sciences. Corning operates in five segments: Display Technologies, which manufactures glass substrates; Optical Communications, which is engaged in providing optical solutions; Environmental Technologies, which manufactures ceramic substrates and filter products; Specialty Materials, which manufactures products that provide more than 150 material formulations for glass, glass ceramics and fluoride crystals, and Life Sciences segment, which is a developer, manufacturer and supplier of scientific laboratory products. The Company manufactures and processes products at approximately 90 plants in 17 countries.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.